BioInformant is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, Xconomy, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant has grown into the world’s largest publisher of stem cell industry news.
Who is BioInformant Today?
Over the past few years, BioInformant’s audience has exploded, turning us into the world’s largest publisher of stem cell industry news. Our audience channel has grown to include: 